Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Molecular Mechanism of Action of Antimalarial Benzoisothiazolones: Species-Selective Inhibitors of the Plasmodium spp. MEP Pathway enzyme, IspD.

Price KE, Armstrong CM, Imlay LS, Hodge DM, Pidathala C, Roberts NJ, Park J, Mikati M, Sharma R, Lawrenson AS, Tolia NH, Berry NG, O'Neill PM, John AR.

Sci Rep. 2016 Nov 18;6:36777. doi: 10.1038/srep36777.

2.

Plasmodium IspD (2-C-Methyl-D-erythritol 4-Phosphate Cytidyltransferase), an Essential and Druggable Antimalarial Target.

Imlay LS, Armstrong CM, Masters MC, Li T, Price KE, Edwards RL, Mann KM, Li LX, Stallings CL, Berry NG, O'Neill PM, Odom AR.

ACS Infect Dis. 2015 Apr 10;1(4):157-167. Epub 2015 Mar 2.

3.

Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation.

Price KE, Orazi G, Ruoff KL, Hebert WP, O'Toole GA, Mastoridis P.

PLoS One. 2015 Oct 27;10(10):e0141192. doi: 10.1371/journal.pone.0141192. eCollection 2015.

4.

Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.

Price KE, Naimie AA, Griffin EF, Bay C, O'Toole GA.

J Bacteriol. 2015 Oct 19;198(2):237-47. doi: 10.1128/JB.00705-15. Print 2016 Jan 15.

5.

Analysis of the Relationship Between Micrognathia and Cleft Palate: A Systematic Review.

Price KE, Haddad Y, Fakhouri WD.

Cleft Palate Craniofac J. 2016 Mar;53(2):e34-44. doi: 10.1597/14-238. Epub 2015 Feb 6. Review.

PMID:
25658963
6.

Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation.

Price KE, Hampton TH, Gifford AH, Dolben EL, Hogan DA, Morrison HG, Sogin ML, O'Toole GA.

Microbiome. 2013 Nov 1;1(1):27. doi: 10.1186/2049-2618-1-27.

7.

Iron supplementation does not worsen respiratory health or alter the sputum microbiome in cystic fibrosis.

Gifford AH, Alexandru DM, Li Z, Dorman DB, Moulton LA, Price KE, Hampton TH, Sogin ML, Zuckerman JB, Parker HW, Stanton BA, O'Toole GA.

J Cyst Fibros. 2014 May;13(3):311-8. doi: 10.1016/j.jcf.2013.11.004. Epub 2013 Dec 13.

8.

Potential of ponatinib to treat chronic myeloid leukemia and acute lymphoblastic leukemia.

Price KE, Saleem N, Lee G, Steinberg M.

Onco Targets Ther. 2013 Aug 20;6:1111-8. doi: 10.2147/OTT.S36980. eCollection 2013.

9.

Flow Heck reactions using extremely low loadings of phosphine-free palladium acetate.

Cyr P, Deng ST, Hawkins JM, Price KE.

Org Lett. 2013 Sep 6;15(17):4342-5. doi: 10.1021/ol4018134. Epub 2013 Aug 12.

PMID:
23937686
10.

Predator odor-evoked BOLD activation in the awake rat: modulation by oxytocin and V₁a vasopressin receptor antagonists.

Reed MD, Price KE, Archbold J, Moffa A, Febo M.

Brain Res. 2013 Feb 4;1494:70-83. doi: 10.1016/j.brainres.2012.11.045. Epub 2012 Dec 3.

11.

Export requirements of pneumolysin in Streptococcus pneumoniae.

Price KE, Greene NG, Camilli A.

J Bacteriol. 2012 Jul;194(14):3651-60. doi: 10.1128/JB.00114-12. Epub 2012 May 4.

12.

17β-Estradiol (E-2) administration to male (NZB × SWR)F₁ mice results in increased Id(LN)F₁-reactive memory T-lymphocytes and accelerated glomerulonephritis.

Feng F, Silvin CJ, Fiore NC, Stoll ML, Price KE, Shanley PS, Silverstone AE, Gavalchin J.

Lupus. 2012 Mar;21(3):288-301. doi: 10.1177/0961203311425519. Epub 2011 Nov 7.

PMID:
22065096
13.

Effects of valproic acid on organic acid metabolism in children: a metabolic profiling study.

Price KE, Pearce RE, Garg UC, Heese BA, Smith LD, Sullivan JE, Kennedy MJ, Bale JF Jr, Ward RM, Chang TK, Abbott FS, Leeder JS.

Clin Pharmacol Ther. 2011 Jun;89(6):867-74. doi: 10.1038/clpt.2011.47. Epub 2011 May 4.

14.

DBU catalysis of N,N'-carbonyldiimidazole-mediated amidations.

Larrivée-Aboussafy C, Jones BP, Price KE, Hardink MA, McLaughlin RW, Lillie BM, Hawkins JM, Vaidyanathan R.

Org Lett. 2010 Jan 15;12(2):324-7. doi: 10.1021/ol9026599.

PMID:
20014771
15.

Mild and efficient DBU-catalyzed amidation of cyanoacetates.

Price KE, Larrivée-Aboussafy C, Lillie BM, McLaughlin RW, Mustakis J, Hettenbach KW, Hawkins JM, Vaidyanathan R.

Org Lett. 2009 May 7;11(9):2003-6. doi: 10.1021/ol900435t.

PMID:
19341310
16.

Pneumolysin localizes to the cell wall of Streptococcus pneumoniae.

Price KE, Camilli A.

J Bacteriol. 2009 Apr;191(7):2163-8. doi: 10.1128/JB.01489-08. Epub 2009 Jan 23.

17.

Development of tissue-targeted metabonomics. Part 1. Analytical considerations.

Price KE, Lunte CE, Larive CK.

J Pharm Biomed Anal. 2008 Mar 13;46(4):737-47. doi: 10.1016/j.jpba.2007.11.035. Epub 2007 Nov 29.

18.

Greener approaches to organic synthesis using microreactor technology.

Mason BP, Price KE, Steinbacher JL, Bogdan AR, McQuade DT.

Chem Rev. 2007 Jun;107(6):2300-18. Epub 2007 Mar 21. Review. No abstract available.

PMID:
17373852
19.

Microencapsulated linear polymers: "soluble" heterogeneous catalysts.

Price KE, Mason BP, Bogdan AR, Broadwater SJ, Steinbacher JL, McQuade DT.

J Am Chem Soc. 2006 Aug 16;128(32):10376-7.

PMID:
16895397
20.

Rapid self-assembly of core-shell organosilicon microcapsules within a microfluidic device.

Steinbacher JL, Moy RW, Price KE, Cummings MA, Roychowdhury C, Buffy JJ, Olbricht WL, Haaf M, McQuade DT.

J Am Chem Soc. 2006 Jul 26;128(29):9442-7.

PMID:
16848481
21.

One-pot multi-step synthesis: a challenge spawning innovation.

Broadwater SJ, Roth SL, Price KE, Kobaslija M, McQuade DT.

Org Biomol Chem. 2005 Aug 21;3(16):2899-906. Epub 2005 Jul 20. Review.

PMID:
16186917
22.

Tissue targeted metabonomics: metabolic profiling by microdialysis sampling and microcoil NMR.

Price KE, Vandaveer SS, Lunte CE, Larive CK.

J Pharm Biomed Anal. 2005 Aug 10;38(5):904-9.

23.

A new interpretation of the Baylis-Hillman mechanism.

Price KE, Broadwater SJ, Walker BJ, McQuade DT.

J Org Chem. 2005 May 13;70(10):3980-7.

PMID:
15876086
24.

A cross-linked reverse micelle-encapsulated palladium catalyst.

Price KE, McQuade DT.

Chem Commun (Camb). 2005 Apr 7;(13):1714-6. Epub 2005 Feb 4.

PMID:
15791308
25.

Baylis-Hillman mechanism: a new interpretation in aprotic solvents.

Price KE, Broadwater SJ, Jung HM, McQuade DT.

Org Lett. 2005 Jan 6;7(1):147-50.

PMID:
15624999
26.

Epitope mapping and competitive binding of HSA drug site II ligands by NMR diffusion measurements.

Lucas LH, Price KE, Larive CK.

J Am Chem Soc. 2004 Nov 3;126(43):14258-66.

PMID:
15506793
27.

Analytical applications of NMR diffusion measurements.

Price KE, Lucas LH, Larive CK.

Anal Bioanal Chem. 2004 Mar;378(6):1405-7. No abstract available.

PMID:
15214402
28.

Synthesis and characterization of cross-linked reverse micelles.

Jung HM, Price KE, McQuade DT.

J Am Chem Soc. 2003 May 7;125(18):5351-5.

PMID:
12720448
29.

The potential for discovery and development of improved aminoglycosides.

Price KE.

Am J Med. 1986 Jun 30;80(6B):182-9. Review.

PMID:
3089002
30.

Aminoglycoside research 1975-1985: prospects for development of improved agents.

Price KE.

Antimicrob Agents Chemother. 1986 Apr;29(4):543-8. Review. No abstract available.

31.

Structural analysis of natural textures.

Vilnrotter FM, Nevatia R, Price KE.

IEEE Trans Pattern Anal Mach Intell. 1986 Jan;8(1):76-89.

PMID:
21869325
32.

Antibacterial activity of phosphanilic acid, alone and in combination with trimethoprim.

Misiek M, Buck RE, Pursiano TA, Chisholm DR, Tsai YH, Price KE, Leitner F.

Antimicrob Agents Chemother. 1985 Dec;28(6):761-5.

34.

Relaxation matching techniques-a comparison.

Price KE.

IEEE Trans Pattern Anal Mach Intell. 1985 May;7(5):617-23.

PMID:
21869299
35.

Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics.

Kessler RE, Bies M, Buck RE, Chisholm DR, Pursiano TA, Tsai YH, Misiek M, Price KE, Leitner F.

Antimicrob Agents Chemother. 1985 Feb;27(2):207-16.

36.

Presence of aminoglycoside acetyltransferase and plasmids in Mycobacterium fortuitum. Lack of correlation with intrinsic aminoglycoside resistance.

Hull SI, Wallace RJ Jr, Bobey DG, Price KE, Goodhines RA, Swenson JM, Silcox VA.

Am Rev Respir Dis. 1984 Apr;129(4):614-8.

PMID:
6712002
37.

Basic design of beta-lactam antibiotics--cephalosporins.

Price KE, McGregor DN.

Scand J Infect Dis Suppl. 1984;42:50-63.

PMID:
6597562
38.

Locating structures in aerial images.

Nevatia R, Price KE.

IEEE Trans Pattern Anal Mach Intell. 1982 May;4(5):476-84.

PMID:
21869066
39.

Evidence for a chromosomal site specifying amikacin resistance in multiresistant Serratia marcescens.

John JF Jr, McNeill WF, Price KE, Kresel PA.

Antimicrob Agents Chemother. 1982 Apr;21(4):587-91.

40.

Epidemiological studies of aminoglycoside resistance in the U.S.A.

Price KE, Kresel PA, Farchione LA, Siskin SB, Karpow SA.

J Antimicrob Chemother. 1981 Jul;8 Suppl A:89-105. No abstract available.

PMID:
7263569
41.

Semantic description of aerial images using stochastic labeling.

Faugeras OD, Price KE.

IEEE Trans Pattern Anal Mach Intell. 1981 Jun;3(6):633-42.

PMID:
21868983
42.

Bactericidal activity of cefadroxil, cephalexin, and cephradine in an in vitro pharmacokinetic model.

Leitner F, Goodhines RA, Buck RE, Price KE.

J Antibiot (Tokyo). 1979 Jul;32(7):718-26.

43.
44.

Cefadroxil, a new broad-spectrum cephalosporin.

Buck RE, Price KE.

Antimicrob Agents Chemother. 1977 Feb;11(2):324-30.

45.

Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates.

Price KE, DeFuria MD, Pursiano TA.

J Infect Dis. 1976 Nov;134 SUPPL:S249-61.

PMID:
62814
46.

Laboratory evaluation of BL-S786, a cephalosporin with broad-spectrum antibacterial activity.

Leitner F, Misiek M, Pursiano TA, Buck RE, Chisholm DR, DeRegis RG, Tsai YH, Price KE.

Antimicrob Agents Chemother. 1976 Sep;10(3):426-35.

47.

Comparative plasma bactericidal activity of cephapirin and cefazolin.

Hottendorf GH, Price KE, Van Harken DR.

Curr Ther Res Clin Exp. 1975 Aug;18(2):364-70. No abstract available.

PMID:
809250
48.

BL-S640, a cephalosporin with a broad spectrum of antibacterial activity: bioavailability and therapeutic properties in rodents.

Leitner F, Chisholm DR, Tsai YH, Wright GE, Deregis RG, Price KE.

Antimicrob Agents Chemother. 1975 Mar;7(3):306-10.

49.

BL-S 640, a cephalosporin with a broad spectrum of antibacterial activity: properties in vitro.

Leitner F, Buck RE, Misiek M, Pursiano TA, Price KE.

Antimicrob Agents Chemother. 1975 Mar;7(3):298-305.

50.

Pneumococcal meningitis-therapeutic studies in mice.

Tsai YH, Williams EB, Hirth RS, Price KE.

Chemotherapy. 1975;21(6):342-57.

PMID:
241610

Supplemental Content

Loading ...
Support Center